Chronic myeloid leukemia (CML) is driven by the oncogenic fusion kinase Bcr-Abl, which organizes its own signaling network with various proteins. These proteins, their interactions, and their role in relevant signaling pathways can be analyzed by quantitative mass spectrometry (MS) approaches in various models systems, e.g., in cell culture models. In this chapter, we describe in detail immunoprecipitations and quantitative proteomics analysis using stable isotope labeling by amino acids in cell culture (SILAC) of components of the Bcr-Abl signaling pathway in the human CML cell line K562.
CITATION STYLE
Halbach, S., Dengjel, J., & Brummer, T. (2016). Quantitative proteomics analysis of Leukemia cells. In Methods in Molecular Biology (Vol. 1465, pp. 139–148). Humana Press Inc. https://doi.org/10.1007/978-1-4939-4011-0_12
Mendeley helps you to discover research relevant for your work.